Establishment and Application of Digital Diagnosis and Treatment System for Sarcopenia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

10000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-09-01

Study Completion Date

2028-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to establish a digital diagnosis and treatment system for sarcopenia, integrating research outcomes into a unified approach encompassing a digital vaccine (early warning screening model), digital drug (intervention model associated with pathogenesis), and digital rehabilitation (preventive system combining early warning and treatment). This aims to create a digital visual tertiary prevention network for sarcopenia.

Research aims:

Evaluate the effectiveness of the digital vaccine through a cross-sectional epidemiological survey.

Establish a specialized cohort for sarcopenia through a longitudinal investigation, implementing the digital drug and digital rehabilitation interventions.

Participants will:

Engage in screening and assessment based on inclusion and exclusion criteria.

Be monitored longitudinally, with tailored interventions for those with muscle atrophy and regular follow-ups for at-risk individuals.

Key outcomes will focus on sarcopenia indicators, serum biomarkers, and clinical endpoints such as fracture rates, weakness classification, and quality of life.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Sarcopenia in Acute Care Patients: Protocol for Sarcopenia 9+

NCT03917667

Sarcopenia

COMPLETED

Multidisciplinary Combined Exercise and Nutrition Intervention for Sarcopenia (2)

NCT07028294

Sarcopenia

COMPLETED NA

The Extremities Rehabilitation Training System for Sarcopenic Hospitalized Aged 80+ Years

NCT04497480

Sarcopenia

UNKNOWN NA

Multidisciplinary Combined Exercise and Nutrition Intervention for Sarcopenia

NCT04948736

Sarcopenia

COMPLETED NA

Muscle Biopsies in Healthy Volunteers

NCT01431677

Sarcopenia Frailty Aging

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sarcopenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥45 years;
* meeting sarcopenia diagnostic criteria;
* consent to participate in this study

Exclusion Criteria

* Age \<45 years;
* patients in acute phase of chronic illness;
* infectious disease patients;
* people who lack of independent mobility;
* people who lack of communication or cognitive skills;
* people who refusal to participate in this study

Minimum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes